Mass Drug Administration to Stop Malaria in Tanzania
Author Information
Author(s): Shekalaghe Seif A, Drakeley Chris, van den Bosch Sven, ter Braak Roel, van den Bijllaardt Wouter, Mwanziva Charles, Semvua Salimu, Masokoto Alutu, Mosha Frank, Teelen Karina, Hermsen Rob, Okell Lucy, Gosling Roly, Sauerwein Robert, Bousema Teun
Primary Institution: Kilimanjaro Christian Medical College-Kilimanjaro Clinical Research Institute, Moshi, Tanzania
Hypothesis
Can mass drug administration with a gametocytocidal drug combination effectively interrupt malaria transmission in a low endemic area?
Conclusion
The study found that despite high coverage of the intervention, there was no observable impact on malaria transmission due to very low pre-existing transmission levels.
Supporting Evidence
- The intervention achieved a coverage rate of 93.0%.
- Parasite prevalence was undetectable during follow-up in both control and intervention clusters.
- Three clinical malaria episodes occurred, one in the intervention and two in the control clusters.
Takeaway
The researchers gave medicine to a lot of people to try to stop malaria, but it didn't work because there were hardly any cases of malaria to begin with.
Methodology
The study used a cluster-randomized trial design with eight clusters receiving the drug combination and eight receiving a placebo, involving active and passive case detection.
Limitations
The study was conducted in an area with very low malaria transmission, making it difficult to assess the impact of the intervention.
Participant Demographics
The study included 5,094 individuals from four villages in Lower Moshi, Tanzania.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website